Research graph
References from Treatment of Experimental Brain Tumors with Trombospondin-1 Derived Peptides: an In Vivo Imaging Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells
1997 · External reference
Antiproliferative and anti-tumor activities of D-reverse peptides from the second type-1 repeat of thrombospondin-1
10.1111/j.1399-3011.1997.tb01187.x · 1997 · External reference
Angiogenesis in cancer, vascular, rheumatoid and other disease
10.1038/nm0195-27 · 1995 · External reference
Angiogenesis and angiogenesis inhibition: an overview
1997 · External reference
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
10.1016/s0092-8674(00)80108-7 · 1996 · External reference
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma
10.1093/jnci/84.24.1875 · 1992 · External reference
Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma
10.3171/jns.1998.88.3.0513 · 1998 · External reference
Angiostatin induces and sustains dormancy of human primary tumors in mice
10.1038/nm0696-689 · 1996 · External reference
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
10.1016/s0092-8674(00)81848-6 · 1997 · External reference
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometas tases with 131l-labeled monoclonal antibodies
1992 · External reference
Tumor vasculature targeted therapies: getting the players organized
10.1016/s0006-2952(98)00011-2 · 1998 · External reference
Targeting gene therapy to cancer: a review
1997 · External reference
Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
1996 · External reference
Unresolved reference
1998 · External reference
Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo
1999 · External reference
Angiostatin suppresses malignant glioma growth in vivo
1998 · External reference
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
10.1073/pnas.95.11.6367 · 1998 · External reference
Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA
1998 · External reference
A tumor suppresser-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
10.1073/pnas.87.17.6624 · 1990 · External reference
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor
10.1083/jcb.111.2.765 · 1990 · External reference
Thrombospondin modulates focal adhesions in endothelial cells
10.1083/jcb.109.3.1309 · 1989 · External reference
Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
10.1002/jcb.240530109 · 1993 · External reference
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
1994 · External reference
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
10.1126/science.7521539 · 1994 · External reference
Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1
1996 · External reference
Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis
10.1073/pnas.92.15.6788 · 1995 · External reference
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic properties
10.1083/jcb.122.2.497 · 1993 · External reference
Novel gliosarcoma cell line expressing green fluorescent protein: a model for quantitative assessment of angiogenesis
10.1006/mvre.1998.2102 · 1998 · External reference
A long-circulating co-polymer in “passive targeting” to solid tumors
10.3109/10611869708995848 · 1997 · External reference
Tumor neovascularity imaging by contrast-enhanced MR angiography
1993 · External reference
A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies
10.1148/radiology.187.3.8497616 · 1993 · External reference
Mapping of tumor vascular and interstitial volume fractions non invasively in vivo
10.1016/s0959-8049(98)00195-6 · 1998 · External reference
Basic physics of MR contrast agents and maximization of image contrast
10.1002/jmri.1880030126 · 1993 · External reference
Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange
10.1002/mrm.1910360608 · 1996 · External reference
Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumors
10.1038/bjc.1988.54 · 1988 · External reference
Intratumoral vascular changes with increased size of a mammary adenocarcinoma: new method and results
1965 · External reference
Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342
10.1002/path.1711570312 · 1989 · External reference
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors
1995 · External reference
Estimating intratumoral microvessel density by different methods to determine angiogenesis in breast cancer: intra- and interobserver variability
1998 · External reference
Antiangiogenic therapy of transgenic mice impairsdenovotumor growth
10.1073/pnas.93.5.2002 · 1996 · External reference
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
10.1038/37126 · 1997 · External reference
Regulation of tumor growth and metastasis by thrombospondin-1
10.1096/fasebj.10.10.8751720 · 1996 · External reference
The role of thrombospondin-1 in tumor progression and angiogenesis
10.1002/bies.950180113 · 1996 · External reference
Expression of thrombospondin-1 in cancer: a role in tumor progression
10.3181/00379727-212-44008 · 1996 · External reference
Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin type 1 peptide
10.1124/mol.55.2.332 · 1999 · External reference
NMR imaging of changes in vascular morphology due to tumor angiogenesis
10.1002/mrm.1910400602 · 1998 · External reference
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
10.1126/science.284.5415.808 · 1999 · External reference
